Related references
Note: Only part of the references are listed.Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus
C. Pan et al.
DIABETES OBESITY & METABOLISM (2012)
Efficacy and safety of saxagliptin in drug-naive Asian patients with type 2 diabetes mellitus: a randomized controlled trial
Chang Yu Pan et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
The addition of sitagliptin to ongoing metformin therapy significantly improves glycemic control in Chinese patients with type 2 diabetes*
Wenying Yang et al.
JOURNAL OF DIABETES (2012)
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
M. -R. Taskinen et al.
DIABETES OBESITY & METABOLISM (2011)
Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study
R. Gomis et al.
DIABETES OBESITY & METABOLISM (2011)
Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial
S. Del Prato et al.
DIABETES OBESITY & METABOLISM (2011)
Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial
Wenying Yang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Efficacy and safety of linagliptin in persons with Type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study
D. R. Owens et al.
DIABETIC MEDICINE (2011)
Hypoglycemic symptoms in patients with type 2 diabetes in Asia-Pacific—Real-life effectiveness and care patterns of diabetes management: The RECAP-DM study
Siew-Pheng Chan et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Prevalence of Diabetes among Men and Women in China
Wenying Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy
R. E. Pratley et al.
DIABETES OBESITY & METABOLISM (2009)
Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea
Viswanathan Mohan et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
A. R. Chacra et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Diabetes in Asia Epidemiology, Risk Factors, and Pathophysiology
Juliana C. N. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose
Kristina M. Utzschneider et al.
DIABETES CARE (2008)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
K. Hermansen et al.
DIABETES OBESITY & METABOLISM (2007)
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective
H-H Parving et al.
KIDNEY INTERNATIONAL (2006)
The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients
WB Chan et al.
DIABETIC MEDICINE (2004)
Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia
H Suzuki et al.
DIABETES CARE (2003)
Ethnic disparities in diabetic complications in an insured population
AJ Karter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
